August 8, 2018 by Chain Drug Review
CVS, earnings, Merlo, Omnicare, pharmacy
Featured Articles, Leading Headlines, Pharmacy, Retail News, Uncategorized
WOONSOCKET, R.I. — Pharmacy gains propelled CVS Health’s second quarter results ahead of Wall Street’s expectations. Retail sales for the three months ended June 30 climbed 5.7% to $20.7 billion, despite less front-end traffic. Overall same-store sales rose 5.9%. Pharmacy sales jumped 8.3% from a year ago, while same-store front-end sales dipped 1%. CVS’ revenue advanced
October 13, 2017 by Chain Drug Review
American Pharmacists Month, CVS Caremark, CVS Health, CVS pharmacists, CVS Pharmacy, CVS Specialty, Larry Merlo, National Pharmacy Technician Day, Omnicare, ScriptPath
Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health is honoring the patient care efforts of its 30,000 pharmacists as part of the annual American Pharmacists Month observation in October. CVS noted that its pharmacy teams are playing an increasingly important role in helping people lead healthier live by improving access to care and lowering costs for the millions
March 13, 2017 by Scot Meyer and Chain Drug Review
CVS Caremark, CVS Health, CVS Health COO, CVS Pharmacy, Jon Roberts, Larry Merlo, MinuteClinic, Omnicare
2017, Issue 03-13-2017, Issues, News
WOONSOCKET, R.I. — CVS Health has named Jon Roberts to the new position of executive vice president and chief operating officer. Roberts, who was president of the CVS Caremark pharmacy benefits management unit, will continue to report to CVS Health president and chief executive officer Larry Merlo. The company said that in his new position
February 9, 2017 by Chain Drug Review
CVS Caremark, CVS Health, CVS Pharmacy, Larry Merlo, Omnicare, Target Corp.
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health topped Wall Street’s earnings-per-share forecast and, driven largely by its PBM unit, saw double-digit sales gains for the 2016 fourth quarter and full year. CVS said Thursday that for the fourth quarter ended Dec. 31, revenue totaled $45.97 billion, up 11.7% from $41.15 billion a year earlier. For the 2016
January 3, 2017 by Jeffrey Woldt and Chain Drug Review
Chain Drug Review, CVS Caremark, CVS Health, CVS Pharmacy, health care delivery, Health Care Executive of the Year, Larry Merlo, MinuteClinic, Omnicare, Target Corp.
2017, Featured Articles, Issue 01-02-2017, Issues, Leading Headlines, News, Retail News
WOONSOCKET, R.I. — As Larry Merlo sees things, health care delivery in the United States is a tale of two incompatible models, a costly, inefficient one rooted in the past, and another focused on a future of increased patient access, improved outcomes and lower costs. “At the moment, it’s as if we have two health
August 2, 2016 by Chain Drug Review
CVS Health, CVS Pharmacy, Larry Merlo, Omnicare, Target Corp.
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — Rising PBM and specialty pharmacy sales and recently acquired pharmacy businesses lifted revenue at CVS Health Corp. for the second quarter, with adjusted earnings per share topping Wall Street’s consensus forecast. CVS Health said Tuesday that for the second quarter ended June 30, sales climbed 17.6% to $43.73 billion from $37.17 billion
May 3, 2016 by Chain Drug Review
CVS Health, CVS Pharmacy, Larry Merlo, Omnicare, Target Corp.
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health reported strong sales gains and topped Wall Street’s consensus earnings forecast for the 2016 first quarter. CVS said Tuesday that for the three months ended March 31, overall revenue climbed 18.9% to $43.2 billion from $36.3 billion a year earlier. Sales in the Retail/LTC Segment, which includes CVS Pharmacy drug stores
February 9, 2016 by Chain Drug Review
CVS Health, Larry Merlo, Omnicare, Target Corp.
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health saw sales climb by double digits for the 2015 fourth quarter and fiscal year, fueled in large part by its acquisition of long-term care pharmacy provider Omnicare Inc., while adjusted earnings per share were in line with Wall Street’s forecast. CVS said Tuesday that revenue for the fourth quarter ended
January 12, 2016 by Chain Drug Review
CVS Health, CVS/pharmacy, John Hammergren, McKesson, Omnicare, Rite Aid, Target Corp.
Business, Featured Articles, Leading Headlines, Pharmacy, Supplier News
SAN FRANCISCO — McKesson Corp. announced a new distribution pact with CVS Health for Target pharmacies in updating its earnings outlook for fiscal 2016 and providing preliminary guidance for fiscal 2017. McKesson said that for the 2016 fiscal year ending March 31, it now projects adjusted earnings per diluted share of $12.60 to $12.90, compared
January 4, 2016 by Geoff Walden and Chain Drug Review
Analyst Day, Cardinal Health, CVS Health, David Denton, Larry Merlo, Omnicare, Red Oak Sourcing, Target Corp.
2016, Business, Issue 01-04-2016, Issues, News
NEW YORK — CVS Health has raised the midpoint of its earnings outlook for 2016 and reiterated its five-year steady state targets. The company now expects next year’s adjusted earnings per share to range from $5.73 to $5.88, reflecting solid year-over-year growth of 11.25% to 14.25%. The bottom end of the range was increased by
January 4, 2016 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, chain drug store business, community pharmacy, CVS Health, Jeffrey Woldt, Omnicare, Rite Aid, Target Corp., Valeant Pharmaceuticals, Walgreens Boots Alliance
2016, Issue 01-04-2016, Issues, Opinion
In many significant ways, the chain drug store business looks very different at the start of 2016 than it did a year ago. Walgreens Boots Alliance, which emerged from a two-step merger process at the close of 2014, spent the past 12 months rationalizing operations in the United States and developing synergies with its retail
December 16, 2015 by John Schultz and Chain Drug Review
CVS Health, CVS/pharmacy, Larry Merlo, Omnicare, Red Oak Sourcing, Target Corp.
Business, Featured Articles, Leading Headlines, Retail News
NEW YORK — At its annual Analyst Day event here, CVS Health updated its earnings guidance for 2016 and reiterated its five-year targets. “Over the past several years, CVS Health has been preparing for the changes in the health care landscape by expanding our extensive suite of leading assets and capabilities,” said president and chief
October 30, 2015 by Chain Drug Review
CVS Health, CVS/pharmacy, Larry Merlo, Omnicare, Target Corp.
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health posted sales gains in both its retail pharmacy and pharmacy services businesses for the 2015 third quarter, with adjusted earnings per share (EPS) finishing in line with analysts’ projections. CVS also said Friday that it has expanded its business segments to incorporate operations from the Omnicare Inc. acquisition, which closed
August 18, 2015 by Chain Drug Review
CVS Health, long-term care, Omnicare, specialty pharmacy
Business, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health has finalized its $12.9 billion acquisition of Omnicare, a leading provider of pharmacy services to long-term care facilities. The completion of the deal, announced Tuesday, came well ahead of the timetable that CVS initially reported when it unveiled the Omnicare acquisition agreement in May. At the time, CVS said it